MSTN may induce insulin resistance by degrading insulin receptor substrate 1 (IRS1) through the E3 ubiquitin ligase Cbl proto‐oncogene B (Cblb) in a Smad3‐dependent manner. Here, IRS1 is linked to Insulin resistance.